RESUMO
BACKGROUND: Growth hormone (GH) has important regulatory effects on cardiac morphology and function both during normal development as well as in pathophysiological settings such as myocardial infarction (MI) and congestive heart failure (CHF). In order to investigate in more detail the interaction between GH and sympathetic nervous system (SNS) system we studied the effects of selective cerebral GH overexpression on myocardial content of catecholamines, myocardial and brain energy metabolism as well as on cardiac function during resting and stress conditions in a transgenic mouse model. METHODS: Transgenic mice with selective bovine GH overexpression under control of glial fibrillary acidic protein promoter in the brain (GFAP-bGH, n=15) were created and compared to genetically matched non-transgenic mates (Control, n=15). Cardiac morphology and function were evaluated in vivo using transthoracic echocardiography during resting and stress conditions induced pharmacologically by dopamine (D) and isoprotenolol (ISO). Myocardial and brain energy metabolism were evaluated non-invasively using in vivo volume-selective phosphorus magnetic resonance spectroscopy ((31)P MRS). Myocardial content of catecholamines was analyzed by means of HPLC. RESULTS: Compared to the C animals, the GFAP-bGH mice have showed several differences in the cardiac phenotype. Systolic (fractional shortening) and diastolic function (E/A wave ratio of mitral flow) was disturbed in the GFAP-bGH mice (both p<0.05). During the dopamine stress, there was chronotropic insufficiency in the GFAP-bGH group (p<0.01) while no difference was observed in response to isoprotenolol. Left ventricular dimensions were increased in GFAP-bGH mice (p<0.05). There was a tendency for higher body weight in GFAP-bGH compared to the control group (p=0.06) while no difference was observed in heart weight and brain weight when normalized for body weight. Myocardial content of noradrenaline was lower in the GFAP-bGH group (p<0.05). PCr/ATP ratio was higher (p<0.05) in the brain and lower in the heart (p<0.05) in the GFAP-bGH mice. CONCLUSIONS: Selective cerebral overexpression of GH results in alterations of cardiac function, morphology and metabolism in transgenic mice. Decreased myocardial content of catecholamines in the GFAP-bGH mice suggests central interaction between GH and sympathetic nervous system.
Assuntos
Encéfalo/metabolismo , Catecolaminas/metabolismo , Metabolismo Energético , Hormônio do Crescimento/biossíntese , Miocárdio/metabolismo , Disfunção Ventricular Esquerda/fisiopatologia , Animais , Bovinos , Dopamina/metabolismo , Dopamina/farmacologia , Ecocardiografia , Feminino , Proteína Glial Fibrilar Ácida/genética , Hormônio do Crescimento/genética , Isoproterenol/farmacologia , Espectroscopia de Ressonância Magnética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Camundongos Transgênicos , Miocárdio/patologia , Regiões Promotoras Genéticas , Estresse Fisiológico/diagnóstico por imagem , Estresse Fisiológico/fisiopatologia , Sistema Nervoso Simpático/fisiologia , Disfunção Ventricular Esquerda/diagnóstico por imagemRESUMO
The effects of long-term chronic growth hormone (GH) excess on lipid and lipoprotein metabolism were investigated in 8-mo-old bovine GH (bGH)-transgenic mice. Total body weight, serum cholesterol, insulin-like growth factor-I, and insulin levels were higher, whereas serum levels of glucose, free fatty acids, and triglycerides were lower in transgenic mice. Very low-density lipoprotein (VLDL) cholesterol levels were lower, and low-density lipoprotein (LDL) cholesterol levels were higher, in transgenic mice irrespective of gender, whereas only transgenic male mice had higher high-density lipoprotein cholesterol levels. Total serum apolipoprotein B (apoB) levels were not affected, but the amount of apoB in the LDL fraction was higher in transgenic mice. Hepatic LDL receptor expression was unchanged, whereas apoB mRNA editing and hepatic triglyceride secretion rate were reduced in bGH-transgenic male mice. Both lipoprotein lipase activity in adipose and heart tissue and beta-adrenergic-stimulated lipolysis were increased in transgenic male mice. The relative weight of adipose tissue was lower in transgenic mice, whereas hepatic triglyceride content was unchanged. Fat feeding of the mice equalized serum triglycerides and free fatty acids in bGH-transgenic and control mice. In summary, long-term GH excess is associated with marked alterations in lipid and lipoprotein metabolism, indicating decreased production and increased degradation of VLDL and preferential flux of fatty acids to muscle tissues.
Assuntos
Hormônio do Crescimento/fisiologia , Lipoproteínas/metabolismo , Animais , Apolipoproteínas B/biossíntese , Glicemia/metabolismo , Western Blotting , Peso Corporal/fisiologia , Colesterol/sangue , Colesterol/metabolismo , Hormônio do Crescimento/biossíntese , Hormônio do Crescimento/genética , Insulina/biossíntese , Fator de Crescimento Insulin-Like I/biossíntese , Lipólise/genética , Lipólise/fisiologia , Lipase Lipoproteica/metabolismo , Lipoproteínas/sangue , Fígado/metabolismo , Camundongos , Camundongos Transgênicos , Tamanho do Órgão/fisiologia , Edição de RNA , RNA Mensageiro/biossíntese , Receptores de LDL/biossíntese , Triglicerídeos/sangue , Triglicerídeos/metabolismoRESUMO
Clinical and experimental studies indicate a role for GH in mechanisms related to anhedonia/hedonia, psychic energy, and reward. Recently we showed that transgenic mice with general overexpression of bovine GH display increased spontaneous locomotor activity. In the present study, we investigated whether this behavioral change is owing to a direct action of GH in the central nervous system or to peripheral GH actions. A transgenic construct, containing the glial fibrillary acidic protein promoter directing specific expression of bovine GH to the central nervous system, was designed. The central nervous system-specific expression of bovine GH in the glial fibrillary acidic protein-bovine GH transgenic mice was confirmed, but no effect on spontaneous locomotor activity was observed. Serum bovine GH levels were increased in glial fibrillary acidic protein-bovine GH transgenic mice but clearly lower than in transgenic mice with general overexpression of bovine GH. In contrast to the transgenic mice with general overexpression of bovine GH, glial fibrillary acidic protein-bovine GH mice did not display any difference in serum IGF-I levels. The levels of free T(3) and the conversion of the free T(4) to free T(3) were only increased in transgenic mice with general overexpression of bovine GH, but serum corticosterone levels were similarly increased in both transgenic models. These results suggest that free T(3) and/or IGF-I, affecting dopamine and serotonin systems in the central nervous system, may mediate the enhanced locomotor activity observed in transgenic mice with general overexpression of bovine GH.
Assuntos
Hormônio do Crescimento/fisiologia , Atividade Motora/fisiologia , Animais , Bovinos , Camundongos , Camundongos TransgênicosRESUMO
Thyroid hormone receptor alpha 1, beta 1 and beta 2-deficient mice (TR alpha 1-/-beta-/- mice) demonstrate growth retardation and defective ossification in the epiphyses associated with an inhibition of the GH/IGF-I axis. There are differences between TR alpha 1-/-beta-/- mice (receptor deficient) and the hypothyroid animal model (ligand deficient). Such differences include possible repressive actions exerted by unliganded receptors in the ligand-deficient (hypothyroid) model but not in the receptor-deficient model. In the present study we have investigated whether or not GH substitution rescues the skeletal phenotype of TR alpha 1-/-beta-/- mice. TR alpha 1-/-beta-/- and wild-type (WT) mice were treated with GH from day 18 until 10 weeks of age. GH substitution of mutant mice resulted in a significant and sustained stimulatory effect on the body weight that was not seen in WT mice. GH-treated mutant mice but not GH-treated WT mice demonstrated increased length and periosteal circumference of the femur. However, GH substitution did not reverse the defective ossification seen in TR alpha 1-/-beta-/- mice. TR alpha 1-/-beta-/- mice displayed increased width of the proximal tibial growth plate, which was caused by increased width of the proliferative but not the hypertrophic layer. GH substitution did not restore the disturbed morphology of the growth plate in TR alpha 1-/-beta-/- mice. In summary, GH substitution reverses the growth phenotype but not the defective ossification in TR alpha 1-/-beta-/- mice. Our data suggest that TRs are of importance both for the regulation of the GH/IGF-I axis and for direct effects on cartilage.
Assuntos
Transtornos do Crescimento/tratamento farmacológico , Transtornos do Crescimento/genética , Hormônio do Crescimento/uso terapêutico , Lâmina de Crescimento/fisiopatologia , Receptores dos Hormônios Tireóideos/genética , Absorciometria de Fóton , Animais , Composição Corporal , Fêmur/fisiopatologia , Deleção de Genes , Transtornos do Crescimento/fisiopatologia , Fator de Crescimento Insulin-Like I/análise , Camundongos , Camundongos Mutantes , Tíbia/fisiopatologia , Tomografia Computadorizada por Raios XRESUMO
Acromegaly is associated with cardiovascular disease. We studied vascular function and mean arterial blood pressure in transgenic mice overexpressing bovine GH. Mean arterial blood pressure was measured in conscious, unrestrained male and female bovine GH and littermate control mice during normal as well as high salt intake using telemetric devices. Structure in artificially perfused maximally dilated hindquarter vascular beds and vascular reactivity and endothelial function in small mesenteric vessels were studied in female bovine GH and control mice. Mean arterial blood pressure was increased in female bovine GH transgenic (126 +/- 3 mm Hg) and male bovine GH transgenic (129 +/- 4 mm Hg) compared with female (109 +/- 3 mm Hg, P < 0.05) and male (111 +/- 3 mm Hg, P < 0.05) controls respectively. Increased salt intake had no effect on mean arterial blood pressure. Perfusion studies showed a significant decrease in the average diameter of the female bovine GH transgenic hindquarter vascular bed (P < 0.05). The responses of isolated resistance arteries to nor-epinephrine, potassium-induced depolarization, acetylcholine, or sodium-nitroprusside did not significantly differ between bovine GH transgenic and control mice. We conclude that the phenotype of the bovine GH transgenic mice includes a salt-resistant form of hypertension. Furthermore, the increase in mean arterial blood pressure is accompanied by a significant structural narrowing of the resistance vasculature without changes in vascular reactivity or endothelial function. The results imply that hypertension in bovine GH transgenic mice is maintained mainly by a structurally based increase in peripheral vascular resistance.
Assuntos
Pressão Sanguínea/efeitos dos fármacos , Hormônio do Crescimento/farmacologia , Membro Posterior/irrigação sanguínea , Circulação Esplâncnica/efeitos dos fármacos , Animais , Vasos Sanguíneos/efeitos dos fármacos , Vasos Sanguíneos/fisiologia , Peso Corporal , Bovinos , Feminino , Hormônio do Crescimento/genética , Coração/anatomia & histologia , Hemodinâmica/efeitos dos fármacos , Rim/efeitos dos fármacos , Rim/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Camundongos Transgênicos/genética , Tamanho do Órgão/efeitos dos fármacos , Valores de Referência , Circulação Esplâncnica/fisiologia , Resistência Vascular/efeitos dos fármacos , VasodilataçãoRESUMO
IGF-I is important for postnatal body growth and exhibits insulin-like effects on carbohydrate metabolism. The function of liver-derived IGF-I is still not established, although we previously demonstrated that liver-derived IGF-I is not required for postnatal body growth. Mice whose IGF-I gene in the liver was inactivated at 24 days of age were used to investigate the long-term role of liver-derived IGF-I for carbohydrate and lipid metabolism. Serum levels of leptin in these mice were increased by >100% at 3 months of age, whereas the fat mass of the mice was decreased by 25% at 13 months of age. The mice became markedly hyperinsulinemic and yet normoglycemic, indicating an adequately compensated insulin resistance. Furthermore, they had increased serum levels of cholesterol. We conclude that liver-derived IGF-I is of importance for carbohydrate and lipid metabolism.
Assuntos
Carboidratos da Dieta/metabolismo , Gorduras na Dieta/metabolismo , Fator de Crescimento Insulin-Like I/fisiologia , Metabolismo dos Lipídeos , Fígado/química , Absorciometria de Fóton , Animais , Glicemia/metabolismo , Composição Corporal/genética , Quimera , Colesterol/sangue , Feminino , Inativação Gênica , Insulina/sangue , Resistência à Insulina/genética , Fator de Crescimento Insulin-Like I/genética , Masculino , Camundongos , Camundongos Endogâmicos C57BLRESUMO
Several clinical observations and experimental studies indicate that pituitary hormones, including growth hormone, play a role in the development of human breast cancer. We analyzed 48 human breast carcinomas using reverse transcription polymerase chain reaction, immunohistochemistry, and Western blotting techniques to assess growth hormone receptor expression. In 17 of these cases, adjacent normal breast tissue was similarly analyzed. These analyses revealed that growth hormone receptor (GHR) is expressed in human breast cancer and appears to be up-regulated compared to adjacent normal breast tissue. GHR expression correlated inversely with tumor grade and MIB-1 index. Progesterone receptor expression correlated positively with GHR expression. These findings, along with our observation of GHR expression in breast cancer stromal cells and previous reports of local production of growth hormone in breast carcinoma, suggest that GHR-mediated signaling pathways are involved in the development of human breast cancer, possibly via autocrine or paracrine mechanisms.
Assuntos
Neoplasias da Mama/metabolismo , Carcinoma/metabolismo , Receptores da Somatotropina/metabolismo , Adulto , Idoso , Western Blotting , Neoplasias da Mama/patologia , Carcinoma/patologia , Feminino , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Valores de Referência , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Regulação para CimaRESUMO
PURPOSE: To determine whether prolactin receptor is essential for normal development and function of the lacrimal gland and whether hyperprolactinemia can alter lacrimal development. METHODS: Lacrimal gland morphology and function were examined in two genetic mouse models of prolactin action: a prolactin receptor knockout model that is devoid of prolactin action and a transgenic model of hyperprolactinemia. RESULTS: Image analysis of lacrimal and Harderian gland sections was used to quantify glandular morphology. In females, lacrimal acinar area decreased by 30% and acinar cell density increased by 25% over control subjects in prolactin transgenic animals, but prolactin receptor knockout mice showed no changes. In males, transgenic animals showed no changes, but prolactin receptor knockout mice showed a 5% reduction in acinar area and an 11% increase in acinar cell density, which was lost after castration. The morphology of the Harderian glands underwent parallel changes but to a lesser degree. A complete loss of porphyrin accretions was seen in the Harderian glands of male and female knockout animals. No differences in tear protein levels were seen in knockout animals by two-dimensional gels. Enzyme-linked immunosorbent assay (ELISA) and Western blot analysis showed that the level of secretory component and IgA in knockout mouse tears remained unchanged. There was no change in the predisposition of the 129 mouse strain to conjunctivitis in the knockout animals. CONCLUSIONS: Prolactin plays a small role in establishing the sexual dimorphism of male lacrimal glands. In females, hyperprolactinemia causes a hyperfemale morphology, suggesting a role in dry eye syndromes. Prolactin is required for porphyrin secretion by the Harderian gland but plays no essential role in the secretory immune function of the lacrimal gland.
Assuntos
Glândula de Harder/citologia , Glândula de Harder/fisiologia , Aparelho Lacrimal/citologia , Aparelho Lacrimal/fisiologia , Prolactina/fisiologia , Animais , Western Blotting , Contagem de Células , Eletroforese em Gel Bidimensional , Ensaio de Imunoadsorção Enzimática , Proteínas do Olho/metabolismo , Feminino , Hiperprolactinemia/genética , Hiperprolactinemia/metabolismo , Masculino , Camundongos , Camundongos Knockout , Camundongos Transgênicos , Receptores da Prolactina/genética , Receptores da Prolactina/fisiologia , Caracteres Sexuais , Lágrimas/metabolismoRESUMO
PURPOSE: This study was an investigation to determine whether human growth hormone (hGH) continuously administered to rabbits may improve implant integration in bone. MATERIALS AND METHODS: Thirty-two commercially pure titanium (c.p. Ti) implants were inserted in the tibiae of 16 rabbits. Human growth hormone (0.3 U/kg/d) or sodium chloride (NaCl) was administered by subcutaneous pumps. Insulin-like growth factor-1 (IGF-1) levels in blood were measured. Two biomechanical tests were performed: (1) every second week resonance frequency analysis (RFA) was used to investigate implant stability or stiffness at the interface and, after 8 weeks of follow-up, (2) removal torque (a measure of implant integration and stability) was registered. Further evaluation was performed by dual energy x-ray analysis (DEXA), to evaluate bone mineral density, and histomorphometric analysis of tissue-to-implant integration on undecalcified cut and ground sections. RESULTS: A difference in implant stability was detected with the RFA technique after 2 weeks and 8 weeks in favor of the hGH-treated rabbits. No significant differences were detected with removal torque, DEXA, and histomorphometric measurements. The blood test demonstrated antibody development in the rabbits treated with hGH after 4 weeks. CONCLUSION: Growth hormone has an initial beneficial effect on implant integration; however, owing to rapid antibody formation, this study did not demonstrate whether this effect remains in the long term.
Assuntos
Osso e Ossos/efeitos dos fármacos , Implantes Dentários , Hormônio do Crescimento Humano/uso terapêutico , Osseointegração , Absorciometria de Fóton , Animais , Anticorpos/sangue , Fenômenos Biomecânicos , Densidade Óssea/efeitos dos fármacos , Matriz Óssea/efeitos dos fármacos , Matriz Óssea/ultraestrutura , Osso e Ossos/cirurgia , Osso e Ossos/ultraestrutura , Seguimentos , Hormônio do Crescimento Humano/administração & dosagem , Hormônio do Crescimento Humano/imunologia , Humanos , Bombas de Infusão Implantáveis , Fator de Crescimento Insulin-Like I/análise , Modelos Animais , Periósteo/efeitos dos fármacos , Periósteo/ultraestrutura , Coelhos , Som , Estatísticas não Paramétricas , Propriedades de Superfície , Tíbia , Titânio , TorqueRESUMO
Cardiovascular abnormalities represent the major cause of death in patients with acromegaly. We evaluated cardiac structure, function, and energy status in adult transgenic mice overexpressing bovine GH (bGH) gene. Female transgenic mice expressing bGH gene (n = 11) 8 months old and aged matched controls (n = 11) were used. They were studied with two-dimensional guided M-mode and Doppler echocardiography. The animals (n = 6) for each group were examined with 31P magnetic resonance spectroscopy to determine the cardiac energy status. Transgenic mice had a significantly higher body weight (BW), 53.2+/-2.4 vs. 34.6+/-3.7 g (P < 0.0001) and hypertrophy of left ventricle (LV) compared with normal controls: LV mass/BW 5.6+/-1.6 vs. 2.7+/-0.2 mg/g, P < 0.01. Several indexes of systolic function were depressed in transgenic animals compared with controls mice such as shortening fraction 25+/-3.0% vs. 39.9+/-3.1%; ejection fraction, 57+/-9 vs. 77+/-5; mean velocity of circumferential shortening, 4.5+/-0.8 vs. 7.0+/-1.1 circ/sec, p < 0.01. Creatine phosphate-to-ATP ratio was significantly lower in bGH overexpressing mice (1.3+/-0.08 vs. 2.1+/-0.23 in controls, P < 0.05). Ultrastructural examination of the hearts from transgenic mice revealed substantial changes of mitochondria. This study provides new insight into possible mechanisms behind the deteriorating effects of long exposure to high level of GH on heart function.
Assuntos
Metabolismo Energético , Expressão Gênica , Hormônio do Crescimento/genética , Cardiopatias/etiologia , Acromegalia/complicações , Trifosfato de Adenosina/metabolismo , Animais , Peso Corporal , Bovinos , Ecocardiografia , Feminino , Hormônio do Crescimento/fisiologia , Cardiopatias/patologia , Cardiopatias/fisiopatologia , Hipertrofia Ventricular Esquerda/etiologia , Hipertrofia Ventricular Esquerda/patologia , Hipertrofia Ventricular Esquerda/fisiopatologia , Espectroscopia de Ressonância Magnética , Camundongos , Camundongos Transgênicos , Miocárdio/metabolismo , Miocárdio/patologia , Tamanho do Órgão , Fosfocreatina/metabolismo , SístoleRESUMO
OBJECTIVES: The main purpose of the present study was to characterize cardiac muscle hypertrophy using both qualitative and quantitative microscopy in mice overexpressing the bovine growth hormone. RESULTS: Measurements of 30 fibres from each group revealed that fibre diameter in transgenic hearts was significantly larger than in control hearts. There was a significant decrease in interfibrillar space in transgenic hearts as compared with control hearts. The enlarged transgenic hearts displayed unchanged organelles such as normal myofibrils and mitochondria in a normal pattern, suggesting balanced growth. Myelin structures were occasionally observed between normal myofibrils. Moreover, myocardial beta-adrenergic receptors and muscarinic receptors in the hearts of transgenic mice overproducing GH were studied to see whether they are involved in the hypertrophic process. It was shown that the density of muscarinic receptors had decreased and the super-high affinity of muscarinic receptors was lost, without any significant changes in either the density or the affinity of beta-adrenergic receptors, as compared with controls. CONCLUSIONS: These results demonstrate that a GH excess was able to induce significant myocardial hypertrophy and that there was a downregulation of muscarinic receptors.
Assuntos
Cardiomegalia/genética , Expressão Gênica , Hormônio do Crescimento/genética , Animais , Ligação Competitiva , Cardiomegalia/metabolismo , Bovinos , Hormônio do Crescimento/metabolismo , Camundongos , Camundongos Transgênicos , Microscopia Eletrônica , Miocárdio/ultraestrutura , Radioimunoensaio , Receptores Adrenérgicos beta/análise , Receptores Muscarínicos/análiseRESUMO
Recent advances in transgenic technology have made the mouse a particularly interesting small animal in cardiovascular research. Increasingly sophisticated experimental methods and tools are needed for detailed characterization of cardiovascular physiology and biochemistry in the mice. The objective of this study was to develop a method for noninvasive evaluation of cardiac energy metabolism in the mouse. Cardiac gated (31)P magnetic resonance spectroscopy using Image Selected in Vivo Spectroscopy (ISIS) method was applied in old mice overexpressing bovine growth hormone (bGH) (n = 5) and control mice (n = 5). The localized volumes of interest were 128 and 112 microL, respectively. Phosphocreatine-to-ATP ratio was 1.5 +/- 0.13 in the bGH mice and 2.1 +/- 0.04 in the control group (P < 0.01). The study demonstrates the feasibility of application of volume-selective (31)P MRS for evaluation of cardiac energy metabolism in the mouse under maintained physiological conditions.
Assuntos
Metabolismo Energético , Hormônio do Crescimento/metabolismo , Coração/fisiologia , Imageamento por Ressonância Magnética/instrumentação , Imageamento por Ressonância Magnética/métodos , Camundongos Transgênicos , Animais , Bovinos , Coração/diagnóstico por imagem , Camundongos , Isótopos de Fósforo , Radiografia , Análise Espectral/métodosRESUMO
This review will focus on the role for prolactin (PRL) and growth hormone (GH) in mammary tumor formation. Much attention has previously been focused on circulating levels of GH/PRL in relation to mammary tumor formation. We will review data demonstrating that these ligands also could be produced locally in different organs, including the mammary gland and mammary tumors, and suggest that this local production may be of importance for pathological conditions. We will also discuss mechanisms for crosstalk between steroids and GH/PRL. A crosstalk between GH- and PRL response is possible at multiple levels. In the human, GH can activate both the prolactin receptor (PRLR) and the growth hormone receptor (GHR). We have demonstrated that activation of the PRLR, but not the GHR, is inducing mammary tumors in transgenic mice. Furthermore, the elevated levels of insulin-like growth factor 1 (IGF-I) seen in the GHR activating transgenic mice is not sufficient for tumor induction. The induced tumors express functionally active prolactin that could be of importance for the tumor formation. Paracrine/aurocrine stimulation by PRL may be more important than PRL transported via the circulation. In women, the role for stimulation of the PRLR and/or the GHR in mammary tumor formation has not been proven, although experiments from primates suggest that the PRLR could be of importance.
Assuntos
Neoplasias da Mama/metabolismo , Hormônio do Crescimento/fisiologia , Prolactina/metabolismo , Animais , Sistema Endócrino/metabolismo , Feminino , Hormônio do Crescimento Humano/metabolismo , Humanos , Neoplasias Mamárias Experimentais/metabolismo , Camundongos , Receptores da Prolactina/metabolismo , Receptores da Somatotropina/metabolismo , Transdução de Sinais , Esteroides/metabolismoRESUMO
Growth hormone (GH) is important for skeletal growth as well as for a normal bone metabolism in adults. The skeletal growth and adult bone metabolism was studied in mice with an inactivated growth hormone receptor (GHR) gene. The lengths of femur, tibia, and crown-rump were, as expected, decreased in GHR-/- mice. Unexpectedly, GHR-/- mice displayed disproportional skeletal growth reflected by decreased femur/crown-rump and femur/tibia ratios. GHR-/- mice demonstrated decreased width of the growth plates in the long bones and disturbed ossification of the proximal tibial epiphysis. Furthermore, the area bone mineral density (BMD) as well as the bone mineral content (BMC)/body weight were markedly decreased in GHR-/- mice. The decrease in BMC in GHR-/- mice was not due to decreased trabecular volumetric BMD but to a decreased cross-sectional cortical bone area In conclusion, GHR-/- mice demonstrate disproportional skeletal growth and markedly decreased bone mineral content.
Assuntos
Densidade Óssea/fisiologia , Desenvolvimento Ósseo/fisiologia , Receptores da Somatotropina/deficiência , Animais , Sequência de Bases , Biomarcadores/sangue , Densidade Óssea/genética , Desenvolvimento Ósseo/genética , Primers do DNA/genética , Fêmur/crescimento & desenvolvimento , Hormônio do Crescimento/fisiologia , Fator de Crescimento Insulin-Like I/genética , Fator de Crescimento Insulin-Like I/metabolismo , Masculino , Camundongos , Camundongos Knockout , Tamanho do Órgão , Especificidade de Órgãos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores da Somatotropina/genética , Tíbia/crescimento & desenvolvimentoRESUMO
Recent clinical and experimental data indicate a role for GH in mechanisms related to anhedonia/hedonia, psychic energy, and reward. In the present study we have investigated whether bovine GH (bGH) transgenic mice and nontransgenic controls differ in spontaneous locomotor activity, a behavioral response related to brain dopamine (DA) and reward mechanisms, as well as in locomotor activity response to drugs of abuse known to interfere with brain DA systems. The animals were tested for locomotor activity once a week for 4 weeks. When first exposed to the test apparatus, bGH transgenic animals displayed significantly more locomotor activity than controls during the entire registration period (1 h). One week later, after acute pretreatment with saline, the two groups did not differ in locomotor activity, whereas at the third test occasion, bGH mice were significantly more stimulated by d-amphetamine (1 mg/kg, ip) than controls. At the fourth test, a tendency for a larger locomotor stimulatory effect of ethanol (2.5 g/kg, ip) was observed in bGH transgenic mice. bGH mice displayed increased tissue levels of serotonin and 5-hydroxyindoleacetic acid in several brain regions, decreased DA levels in the brain stem, and decreased levels of the DA metabolite 3,4-dihydroxyphenylacetic acid in the mesencephalon and diencephalon, compared with controls. In conclusion, bGH mice display more spontaneous locomotor activity than nontransgenic controls in a novel environment and possibly also a disturbed habituation process. The finding that bGH mice were also more sensitive to d-amphetamine-induced locomotor activity may suggest that the behavioral differences observed are related to differences in brain DA systems, indicating a hyperresponsiveness of these systems in bGH transgenic mice. These findings may constitute a neurochemical basis for the reported psychic effects of GH in humans.
Assuntos
Monoaminas Biogênicas/metabolismo , Encéfalo/metabolismo , Expressão Gênica , Hormônio do Crescimento/genética , Atividade Motora/fisiologia , Ácido 3,4-Di-Hidroxifenilacético/metabolismo , Animais , Bovinos , Dextroanfetamina/farmacologia , Dopamina/metabolismo , Etanol/farmacologia , Hormônio do Crescimento/fisiologia , Ácido Hidroxi-Indolacético/metabolismo , Camundongos , Camundongos Transgênicos , Atividade Motora/efeitos dos fármacos , Recompensa , Serotonina/metabolismoRESUMO
Here we have investigated the role of autocrine production of human growth hormone (hGH) in the proliferation of mammary carcinoma cells (MCF-7) in vitro. MCF-7 cells were stably transfected with an expression plasmid encoding the hGH gene, and these cells (designated MCF-hGH) synthesized hGH in the cell and secreted hGH to the medium. For control purposes, a MCF cell line was generated (MCF-MUT) in which the start codon of the hGH gene was disabled, and these cells transcribed the hGH gene without translation to hGH protein. The MCF-hGH cell number increased at a rate significantly greater than that of MCF-MUT under serum-free conditions. Autocrine hGH also synergized with 10% serum and insulin-like growth factor-1 but not 17-beta-estradiol to increase cell number. The increased proliferation of MCF-hGH cells in both serum-free and serum-containing media could be completely abrogated by the use of the nonreceptor dimerizing hGH antagonist, hGH-G120R. Increased mitogenesis as a consequence of autocrine production of hGH was prevented by inhibition of either the p38 MAPK or p42/44 MAPK pathways. MCF-hGH cells also possessed a higher level of STAT5 (but not STATs 1 and 3) mediated transcriptional activation in both serum-free and serum-containing conditions than MCF-MUT cells. Thus we conclude that hGH can act in an autocrine/paracrine manner in human mammary carcinoma cells to promote cell proliferation and transcriptional activation.
Assuntos
Adenocarcinoma/patologia , Comunicação Autócrina , Neoplasias da Mama/patologia , Mama/patologia , Hormônio do Crescimento Humano/fisiologia , Proteínas do Leite , Proteínas Quinases Ativadas por Mitógeno , Proteínas Proto-Oncogênicas , Proteínas Recombinantes , Animais , Mama/metabolismo , Proteínas Quinases Dependentes de Cálcio-Calmodulina/antagonistas & inibidores , Divisão Celular/efeitos dos fármacos , Proteínas de Ligação a DNA/biossíntese , Estradiol/farmacologia , Feminino , Hormônio do Crescimento/análogos & derivados , Hormônio do Crescimento/farmacologia , Antagonistas de Hormônios/farmacologia , Hormônio do Crescimento Humano/biossíntese , Hormônio do Crescimento Humano/genética , Hormônio do Crescimento Humano/farmacologia , Humanos , Fator de Crescimento Insulin-Like I/farmacologia , Janus Quinase 1 , Janus Quinase 2 , Proteína Quinase 1 Ativada por Mitógeno/antagonistas & inibidores , Proteínas Tirosina Quinases/biossíntese , Receptores da Somatotropina/biossíntese , Receptores da Somatotropina/genética , Fator de Transcrição STAT1 , Fator de Transcrição STAT3 , Fator de Transcrição STAT5 , Transativadores/biossíntese , Células Tumorais Cultivadas , Proteínas Quinases p38 Ativadas por MitógenoRESUMO
The body growth of animals is regulated by growth hormone and IGF-I. The classical theory of this regulation is that most IGF-I in the blood originates in the liver and that body growth is controlled by the concentration of IGF-I in the blood. We have abolished IGF-I production in the livers of mice by using the Cre/loxP recombination system. These mice demonstrated complete inactivation of the IGF-I gene in the hepatocytes. Although the liver accounts for less than 5% of body mass, the concentration of IGF-I in the serum was reduced by 75%. This finding confirms that the liver is the principal source of IGF-I in the blood. However, the reduction in serum IGF-I concentration had no discernible effect on postnatal body growth. We conclude that postnatal body growth is preserved despite complete absence of IGF-I production by the hepatocytes.
Assuntos
Envelhecimento/metabolismo , Fator de Crescimento Insulin-Like I/biossíntese , Fígado/metabolismo , Animais , Peso Corporal , Fator de Crescimento Insulin-Like I/deficiência , Fator de Crescimento Insulin-Like I/genética , Camundongos , Camundongos KnockoutRESUMO
Islet amyloid polypeptide (IAPP or amylin) is costored and cosecreted with insulin and may regulate insulin secretion and blood glucose handling. However, the role and importance of endogenous IAPP in the regulation of insulin release and glucose homeostasis have been controversial. Here we report on the generation and phenotypic analysis of IAPP-deficient mice. These mice have normal, or near to normal, basal levels of circulating insulin and glucose. However, following glucose administration, IAPP-deficient males presented increased insulin responses paralleled with a more rapid blood glucose elimination compared to wild-type controls. Blood glucose elimination was also found to be enhanced in IAPP-deficient females, but the insulin response in this gender did not differ from controls. In a transgenic rescue experiment, using an insulin-promoter human-IAPP fusion gene, insulin responses and blood glucose elimination were reversed in IAPP-deficient males, whereas the female phenotype appeared unaffected. Our results provide the first firm evidence of a physiological role for endogenous IAPP and indicate that IAPP, apparently in a gender-dependent manner, limits the degree of glucose-induced insulin secretion and the rate of blood glucose elimination.
Assuntos
Amiloide/deficiência , Glicemia/metabolismo , Insulina/metabolismo , Amiloide/genética , Animais , Feminino , Deleção de Genes , Teste de Tolerância a Glucose , Humanos , Insulina/sangue , Secreção de Insulina , Polipeptídeo Amiloide das Ilhotas Pancreáticas , Masculino , Camundongos , Ratos , Fatores SexuaisRESUMO
An altered endocrine status of elderly men has been hypothesized to be important for development of prostate hyperplasia. The present study addresses the question whether increased PRL expression is of importance for development of prostate hyperplasia in mice. Three lines of PRL transgenic mice were generated having serum levels of PRL of approximately 15 ng/ml, 100 ng/ml, and 250 ng/ml, respectively. These mice developed dramatic enlargement of the prostate gland, approximately 20 times the normal prostate weight and they had a 4- to 5-fold increased DNA content. Histologically, the prostate glands in the transgenic mice were distended from secretion, and the amount of interstitial tissue was increased. The levels oftestosterone and IGF-I were increased in the PRL transgenic animals. In mice overexpressing the bovine GH gene, displaying elevated IGF-I levels, the prostate gland was slightly larger compared with normal mice, indicating that the effect of PRL was not primarily mediated through elevated plasma IGF-I levels. The present study suggests that PRL is an important factor in the development of prostate hyperplasia acting directly on the prostate gland or via increased plasma levels of testosterone.
Assuntos
Camundongos Transgênicos/genética , Prolactina/genética , Prolactina/fisiologia , Próstata/patologia , Hiperplasia Prostática/etiologia , Animais , Sequência de Bases , Bovinos , DNA/análise , DNA/química , DNA/genética , Modelos Animais de Doenças , Feminino , Regulação da Expressão Gênica , Fator de Crescimento Insulin-Like I/metabolismo , Masculino , Camundongos , Camundongos Transgênicos/metabolismo , Reação em Cadeia da Polimerase , Prolactina/metabolismo , Próstata/crescimento & desenvolvimento , Próstata/metabolismo , Hiperplasia Prostática/metabolismo , Hiperplasia Prostática/patologia , Testosterona/sangueRESUMO
Several recent studies have investigated the effects of growth hormone (GH) on the healing of fractures and bone ingrowth, but with conflicting results. The negative results may be due to antibody formation against injected GH or because some experimental models are able to prove only positive GH effects. In this study, we wanted to investigate the effect of GH on implant integration in bone. To avoid potential formation of antibodies against injected GH, we used a model with transgenic mice overexpressing bovine GH (bGH). Titanium implants were inserted in the forehead of the mice. 4 months after insertion, the implants were cut out en bloc with the surrounding bone. The calcified specimens were cut and ground to a thickness of approximately 10 microns. Histomorphometry demonstrated significantly more direct bone-to-metal contact in the transgenic mice than in the nontransgenic littermates. Our findings indicate that systemic administration of GH in humans may improve implant integration in bone.